메뉴 건너뛰기




Volumn 98, Issue 5, 2003, Pages 978-982

Gemcitabine added to doxorubicin, bleomycin, and vinblastine for the treatment of De Novo Hodgkin disease: Unacceptable acute pulmonary toxicity

Author keywords

Bleomycin; Gemcitabine; Hodgkin disease; Pneumonitis

Indexed keywords

BLEOMYCIN; CARBON MONOXIDE; CORTICOSTEROID; DACARBAZINE; DOXORUBICIN; GEMCITABINE; GRANULOCYTE COLONY STIMULATING FACTOR; VINBLASTINE;

EID: 0041386295     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/cncr.11582     Document Type: Article
Times cited : (48)

References (27)
  • 1
    • 0026439199 scopus 로고
    • Chemotherapy of advanced Hodgkin's disease with MOPP, ABVD, or MOPP alternating with ABVD
    • Canellos GP, Anderson JR, Propert KJ, et al. Chemotherapy of advanced Hodgkin's disease with MOPP, ABVD, or MOPP alternating with ABVD. N Engl J Med. 1992;327:1478-1484.
    • (1992) N Engl J Med , vol.327 , pp. 1478-1484
    • Canellos, G.P.1    Anderson, J.R.2    Propert, K.J.3
  • 2
    • 0037007678 scopus 로고    scopus 로고
    • Long-term follow-up of Hodgkin's disease trial
    • Canellos GP, Niedzwiecki D. Long-term follow-up of Hodgkin's disease trial. N Engl J Med. 2002;346:1417-1418.
    • (2002) N Engl J Med , vol.346 , pp. 1417-1418
    • Canellos, G.P.1    Niedzwiecki, D.2
  • 3
    • 0037441660 scopus 로고    scopus 로고
    • Advanced Hodgkin's disease: ABVD is better, yet is not good enough&excl
    • Diehl V. Advanced Hodgkin's disease: ABVD is better, yet is not good enough! J Clin Oncol. 2003;21:583-585.
    • (2003) J Clin Oncol , vol.21 , pp. 583-585
    • Diehl, V.1
  • 4
    • 0032548107 scopus 로고    scopus 로고
    • A prognostic score for advanced Hodgkin's disease. International prognostic factors project on advanced Hodgkin's disease
    • Hasenclever D, Diehl V. A prognostic score for advanced Hodgkin's disease. International Prognostic Factors Project on Advanced Hodgkin's Disease [see comments]. N Engl J Med. 1998;339:1506-1514.
    • (1998) N Engl J Med , vol.339 , pp. 1506-1514
    • Hasenclever, D.1    Diehl, V.2
  • 5
    • 0036467658 scopus 로고    scopus 로고
    • Stanford V and radiotherapy for locally extensive and advanced Hodgkin's disease: Mature results of a prospective clinical trial
    • Horning SJ, Hoppe RT, Breslin S, Bartlett NL, Brown BW, Rosenberg SA. Stanford V and radiotherapy for locally extensive and advanced Hodgkin's disease: mature results of a prospective clinical trial. J Clin Oncol. 2002;20:630-637.
    • (2002) J Clin Oncol , vol.20 , pp. 630-637
    • Horning, S.J.1    Hoppe, R.T.2    Breslin, S.3    Bartlett, N.L.4    Brown, B.W.5    Rosenberg, S.A.6
  • 6
    • 0032422646 scopus 로고    scopus 로고
    • BEACOPP, a new dose-escalated and accelerated regimen, is at least as effective as COPP/ABVD in patients with advanced-stage Hodgkin's lymphoma: Interim report from a trial of the German Hodgkin's Lymphoma Study Group
    • Diehl V, Franklin J, Hasenclever D, et al. BEACOPP, a new dose-escalated and accelerated regimen, is at least as effective as COPP/ABVD in patients with advanced-stage Hodgkin's lymphoma: interim report from a trial of the German Hodgkin's Lymphoma Study Group. J Clin Oncol. 1998;16:3810-3821.
    • (1998) J Clin Oncol , vol.16 , pp. 3810-3821
    • Diehl, V.1    Franklin, J.2    Hasenclever, D.3
  • 7
    • 0033650534 scopus 로고    scopus 로고
    • Autologous hematopoietic cell transplantation in Hodgkin's disease
    • Johnston LJ, Horning SJ. Autologous hematopoietic cell transplantation in Hodgkin's disease. Biol Blood Marrow Transplant. 2000;6:289-300.
    • (2000) Biol Blood Marrow Transplant , vol.6 , pp. 289-300
    • Johnston, L.J.1    Horning, S.J.2
  • 8
    • 0035281922 scopus 로고    scopus 로고
    • Autologous stem-cell transplantation for Hodgkin's disease: Results and prognostic factors in 494 patients from the Grupo Espanol de Linfomas/Transplante Autologo de Medula Osea Spanish Cooperative Group
    • Sureda A, Arranz R, Iriondo A, et al. Autologous stem-cell transplantation for Hodgkin's disease: results and prognostic factors in 494 patients from the Grupo Espanol de Linfomas/Transplante Autologo de Medula Osea Spanish Cooperative Group. J Clin Oncol. 2001;19:1395-1404.
    • (2001) J Clin Oncol , vol.19 , pp. 1395-1404
    • Sureda, A.1    Arranz, R.2    Iriondo, A.3
  • 9
    • 0037105618 scopus 로고    scopus 로고
    • Second malignancy after Hodgkin disease treated with radiation therapy with or without chemotherapy: Long-term risks and risk factors
    • Ng AK, Bernardo MV, Weller E, et al. Second malignancy after Hodgkin disease treated with radiation therapy with or without chemotherapy: long-term risks and risk factors. Blood. 2002;100:1989-1996.
    • (2002) Blood , vol.100 , pp. 1989-1996
    • Ng, A.K.1    Bernardo, M.V.2    Weller, E.3
  • 10
    • 0030870485 scopus 로고    scopus 로고
    • Gemcitabine. A review of its pharmacology and clinical potential in non-small cell lung cancer and pancreatic cancer
    • Noble S, Goa KL. Gemcitabine. A review of its pharmacology and clinical potential in non-small cell lung cancer and pancreatic cancer. Drugs. 1997;54:447-472.
    • (1997) Drugs , vol.54 , pp. 447-472
    • Noble, S.1    Goa, K.L.2
  • 12
    • 0033782490 scopus 로고    scopus 로고
    • Value of gemcitabine treatment in heavily pretreated Hodgkin's disease patients
    • Zinzani PL, Bendandi M, Stefoni V, et al. Value of gemcitabine treatment in heavily pretreated Hodgkin's disease patients. Haematologica. 2000;85:926-929.
    • (2000) Haematologica , vol.85 , pp. 926-929
    • Zinzani, P.L.1    Bendandi, M.2    Stefoni, V.3
  • 13
    • 0033932803 scopus 로고    scopus 로고
    • Gemcitabine in the treatment of refractory Hodgkin's disease: Results of a multicenter Phase II study
    • Santoro A, Bredenfeld H, Devizzi L, et al. Gemcitabine in the treatment of refractory Hodgkin's disease: results of a multicenter Phase II study. J Clin Oncol. 2000;18:2615-2619.
    • (2000) J Clin Oncol , vol.18 , pp. 2615-2619
    • Santoro, A.1    Bredenfeld, H.2    Devizzi, L.3
  • 15
    • 0024422603 scopus 로고
    • Report of a committee convened to discuss the evaluation and staging of patients with Hodgkin's disease: Cotswolds meeting
    • published erratum appears in J Clin Oncol 1990;8:1602
    • Lister TA, Crowther D, Sutcliffe SB, et al. Report of a committee convened to discuss the evaluation and staging of patients with Hodgkin's disease: Cotswolds meeting [published erratum appears in J Clin Oncol. 1990;8:1602] [see comments]. J Clin Oncol. 1989;7:1630-1636.
    • (1989) J Clin Oncol , vol.7 , pp. 1630-1636
    • Lister, T.A.1    Crowther, D.2    Sutcliffe, S.B.3
  • 16
    • 0025117688 scopus 로고
    • Fatal pulmonary failure complicating high-dose cytosine arabinoside therapy in acute leukemia
    • Andersson BS, Luna MA, Yee C, Hui KK, Keating MJ, McCredie KB. Fatal pulmonary failure complicating high-dose cytosine arabinoside therapy in acute leukemia. Cancer. 1990;65:1079-1084.
    • (1990) Cancer , vol.65 , pp. 1079-1084
    • Andersson, B.S.1    Luna, M.A.2    Yee, C.3    Hui, K.K.4    Keating, M.J.5    McCredie, K.B.6
  • 17
    • 0030996855 scopus 로고    scopus 로고
    • Fatal pulmonary toxicity resulting from treatment with gemcitabine
    • Pavlakis N, Bell DR, Millward MJ, Levi JA. Fatal pulmonary toxicity resulting from treatment with gemcitabine. Cancer. 1997;80:286-291.
    • (1997) Cancer , vol.80 , pp. 286-291
    • Pavlakis, N.1    Bell, D.R.2    Millward, M.J.3    Levi, J.A.4
  • 23
    • 4243708016 scopus 로고    scopus 로고
    • BAGCOPP - A follow up report on a pilot study with a modified BEACOPP regimen showing unexpected acute toxicity in patients with advanced-stage Hodgkin's disease
    • Bredenfeld H, Fries S, Meisner M, et al. BAGCOPP - a follow up report on a pilot study with a modified BEACOPP regimen showing unexpected acute toxicity in patients with advanced-stage Hodgkin's disease [abstract]. Blood. 2002;100:295b.
    • (2002) Blood , vol.100
    • Bredenfeld, H.1    Fries, S.2    Meisner, M.3
  • 24
    • 0026850260 scopus 로고
    • Bleomycin pulmonary toxicity: Current status and future directions
    • Comis RL. Bleomycin pulmonary toxicity: current status and future directions. Semin Oncol. 1992;19(2 Suppl 5): 64-70.
    • (1992) Semin Oncol , vol.19 , Issue.2 SUPPL. 5 , pp. 64-70
    • Comis, R.L.1
  • 26
    • 0037441857 scopus 로고    scopus 로고
    • Randomized comparison of ABVD and MOPP/ABV hybrid for the treatment of advanced Hodgkin's disease: Report of an intergroup trial
    • Duggan DB, Petroni GR, Johnson JL, et al. Randomized comparison of ABVD and MOPP/ABV hybrid for the treatment of advanced Hodgkin's disease: report of an intergroup trial. J Clin Oncol. 2003;21:607-614.
    • (2003) J Clin Oncol , vol.21 , pp. 607-614
    • Duggan, D.B.1    Petroni, G.R.2    Johnson, J.L.3
  • 27
    • 79960971262 scopus 로고    scopus 로고
    • Results of a prospective randomized trial of doxorubicin, bleomycin, vinblastine, and dacarbazine (ABVD) alone vs. ABVD + radiation therapy for early stage non-bulky Hodgkin's disease
    • Straus DJ, Yahalom J, Zelenetz AD, et al. Results of a prospective randomized trial of doxorubicin, bleomycin, vinblastine, and dacarbazine (ABVD) alone vs. ABVD + radiation therapy for early stage non-bulky Hodgkin's disease [abstract]. Blood. 2001;98:769a.
    • (2001) Blood , vol.98
    • Straus, D.J.1    Yahalom, J.2    Zelenetz, A.D.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.